107 related articles for article (PubMed ID: 26995093)
1. Catanionic lipid nanosystems improve pharmacokinetics and anti-lung cancer activity of curcumin.
Li S; Fang C; Zhang J; Liu B; Wei Z; Fan X; Sui Z; Tan Q
Nanomedicine; 2016 Aug; 12(6):1567-79. PubMed ID: 26995093
[TBL] [Abstract][Full Text] [Related]
2. A supermolecular curcumin for enhanced antiproliferative and proapoptotic activities: molecular characteristics, computer modeling and in vivo pharmacokinetics.
Tan Q; Wu J; Li Y; Mei H; Zhao C; Zhang J
Nanotechnology; 2013 Jan; 24(3):035102. PubMed ID: 23262762
[TBL] [Abstract][Full Text] [Related]
3. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules.
Lollo G; Ullio-Gamboa G; Fuentes E; Matha K; Lautram N; Benoit JP
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():859-867. PubMed ID: 30033321
[TBL] [Abstract][Full Text] [Related]
5. Catanionic Hybrid Lipid Nanovesicles for Improved Bioavailability and Efficacy of Chemotherapeutic Drugs.
Xie X; He D; Wu Y; Wang T; Zhong C; Zhang J
Methods Mol Biol; 2021; 2211():57-68. PubMed ID: 33336270
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
7. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
Jin H; Qiao F; Wang Y; Xu Y; Shang Y
Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of natural polyphenol-loaded natural polysaccharide-cloaked lipidic nanocarriers to improve efficacy against small-cell lung cancer.
Xie X; Li Y; Zhao D; Fang C; He D; Yang Q; Yang L; Chen R; Tan Q; Zhang J
Nanomedicine; 2020 Oct; 29():102261. PubMed ID: 32621880
[TBL] [Abstract][Full Text] [Related]
10. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
[TBL] [Abstract][Full Text] [Related]
12. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.
Kang JH; Kang HS; Kim IK; Lee HY; Ha JH; Yeo CD; Kang HH; Moon HS; Lee SH
Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014
[TBL] [Abstract][Full Text] [Related]
13. One-Step Synthesis of Nanoscale Zeolitic Imidazolate Frameworks with High Curcumin Loading for Treatment of Cervical Cancer.
Zheng M; Liu S; Guan X; Xie Z
ACS Appl Mater Interfaces; 2015 Oct; 7(40):22181-7. PubMed ID: 26403308
[TBL] [Abstract][Full Text] [Related]
14. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
Zhao Z; Li C; Xi H; Gao Y; Xu D
Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
[TBL] [Abstract][Full Text] [Related]
15. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
17. Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics.
Cheng KW; Wong CC; Mattheolabakis G; Xie G; Huang L; Rigas B
Int J Oncol; 2013 Sep; 43(3):895-902. PubMed ID: 23807084
[TBL] [Abstract][Full Text] [Related]
18. Composite alkali polysaccharide supramolecular nanovesicles improve biocharacteristics and anti-lung cancer activity of natural phenolic drugs via oral administration.
Huang Y; Hu X; Zhao H; He D; Li Y; Yang M; Yu Z; Li K; Zhang J
Int J Pharm; 2020 Jan; 573():118864. PubMed ID: 31765782
[TBL] [Abstract][Full Text] [Related]
19. Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.
Anisuzzaman AS; Haque A; Rahman MA; Wang D; Fuchs JR; Hurwitz S; Liu Y; Sica G; Khuri FR; Chen ZG; Shin DM; Amin AR
Cancer Prev Res (Phila); 2016 Jan; 9(1):63-73. PubMed ID: 26511491
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]